[Problems in the current treatment of the bronchial obstruction syndrome in bronchial asthma patients].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001249:Asthma / Q000150:complications* / Q000188:drug therapy; D001986:Bronchial Spasm / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D013577:Syndrome
D000317:Adrenergic alpha-Antagonists; D001993:Bronchodilator Agents; D010276:Parasympatholytics; D010726:Phosphodiesterase Inhibitors; D011465:Prostaglandins, Synthetic; D013566:Sympathomimetics
Nekotorye voprosy sovremennogo lecheniia bronkhoobturatsionnogo sindroma u bol'nykh bronkhial'noĭ astmoĭ.